Assessing infection risks in digestive endoscopy environments
Risk Assessment of Indirect Exposure to the Environment in the Gastrointestinal Endoscopy Center
NA · Peking Union Medical College Hospital · NCT05321043
This study is testing how germs might spread in a digestive endoscopy center by looking at where patients touch and how it could lead to infections.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 100 (estimated) |
| Sex | All |
| Sponsor | Peking Union Medical College Hospital (other) |
| Locations | 1 site (Beijing) |
| Trial ID | NCT05321043 on ClinicalTrials.gov |
What this trial studies
This study aims to evaluate the risk of indirect exposure and transmission of infections in a digestive endoscopy center by simulating contact with environmental surfaces using a Vitamin B2 solution. The research involves analyzing key exposure areas within the endoscopy room and marking patients' hands with a fluorescent marker before their procedures. The study records the endoscopy process and assesses the residual fluorescence on surfaces after the procedures to understand touch behaviors and potential contamination. This case-only design focuses on identifying high-risk areas to improve infection control protocols.
Who should consider this trial
Good fit: Ideal candidates include patients scheduled for gastroscopy at the digestive endoscopy center, regardless of age or gender.
Not a fit: Patients who are allergic to Vitamin B2 or have severe health conditions that contraindicate endoscopy may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance infection control measures in endoscopy centers, leading to safer procedures for patients and healthcare staff.
How similar studies have performed: While studies on infection control in medical settings exist, this specific approach using Vitamin B2 for indirect exposure assessment is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * During the study period, patients who were treated in the digestive endoscopy center of Beijing Union Medical College Hospital and planned to undergo gastroscopy. Age and gender are not limited temporarily. Exclusion Criteria: * Allergic to medical non-toxic fluorescent agent: Vitamin B2 aqueous solution. * Poor general condition, including severe cardiopulmonary disease, difficult to tolerate examination, and coagulation disorders. * Patients with contraindications to endoscopy.
Where this trial is running
Beijing
- Peking Union Medical College Hospital — Beijing, China (RECRUITING)
Study contacts
- Principal investigator: Yuheng Zhang, MD candidate — Peking Union Medical College Hospital
- Study coordinator: Shengyu Zhang, M.D.
- Email: pumchzsy@126.com
- Phone: +8618501155701
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Infection Control, infection control, indirect contagion transmission, digestive endoscopy center